№ files_lp_4_process_3_103561
File format: docx Character count: 2644 File size: 28 KB
This document provides detailed instructions for administering mistletoe injections as part of a long-term treatment protocol, including dosage schedules and how to respond to skin reactions.
Year: Not specified
Region / City: Not specified
Topic: Mistletoe therapy dosing
Document type: Medical Guide
Organization / Institution: Not specified
Author: Not specified
Target audience: Patients receiving mistletoe therapy
Duration: Long-term therapy
Approval date: Not specified
Modification date: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Best Practice Message on Ondansetron Dosing and Interactions – March 2025
Year: 2025
Region / City: Aotearoa
Topic: Ondansetron usage, dosing guidelines, drug interactions
Document Type: Medical Best Practice Guide
Organization / Institution: HealthPathways, Health New Zealand, Te Whatu Ora
Author: Riani Albertyn, Brendan Duck
Target Audience: Healthcare professionals
Period of Validity: 2025
Approval Date: March 2025
Date of Changes: January 2024
TMS1636Asset Specification for Hypochlorite and MonOchloramine Chemical Dosing Units
Year: 2024
Region / City: South-East Queensland
Topic: Water treatment, chemical dosing units
Document Type: Technical Specification
Organization: Urban Utilities
Author: Santhosh Jambagi
Target Audience: Designers, constructors, and stakeholders involved in chemical dosing systems for water infrastructure
Period of Validity: From 31/10/2024
Approval Date: 31/10/2024
Date of Revision: 31/10/2024
PROTOCOL: Vancomycin Collaborative Practice Dosing Protocol
Year: 2013
Region / city: United States
Topic: Clinical guidelines for vancomycin dosing and management
Document type: Clinical Protocol
Organization / Institution: UConn Health – John Dempsey Hospital
Author: Director of Pharmacy, Dept. of Infectious Diseases
Target audience: Licensed Prescribers, Pharmacists, Nurses
Period of validity: Ongoing
Approval date: 10/30/13
Last revision date: 10/2020
PROTOCOL: Aminoglycoside Collaborative Practice Dosing Protocol
Year: 2019
Region / city: UConn Health – John Dempsey Hospital
Theme: Clinical Practice
Document Type: Protocol
Organization / institution: UConn Health, Department of Pharmacy, Department of Infectious Diseases
Author: John Dempsey Hospital Pharmacy Department
Target audience: Licensed Prescribers, Pharmacists, Nurses
Effective Period: Not specified
Approval Date: 1/9/19
Date of Last Revision: Not specified
Date Retired: Not specified
Opioid dosing threshold policy for non-malignant pain
Year: 2019
Organization: The Royal Australian College of General Practitioners (RACGP)
Document type: Policy template
Purpose: Safe limitations for prescribing opioid medication
Scope: Non-malignant pain
Current as of: [insert date of last revision]
Version no: [insert version number]
Review date: [insert date]
Target audience: General practitioners
Source: RACGP Clinical Governance Framework
Decoding CRRT: Principles of Continuous Renal Replacement Therapies & Drug Dosing Considerations in Patient Care – August 19, 2024
Year: 2024
Date: August 19, 2024
Location: Adventist Health Glendale Hospital, 1509 Wilson Terrace, Glendale, CA 91206
Venue: Wu Auditorium, East Tower, Ground Floor
Organizing Body: SGVSHP
Speaker: Jignesh H. Patel, Pharm.D., B.Sc.
Affiliation: Western University of Health Sciences, College of Pharmacy
Department: Pharmacy Practice and Administration
Target Audience: Pharmacists, Technicians
Activity Type: Knowledge-based Continuing Education
Continuing Education Credit: Available
CE Fee: No charge for CSHP members
Time: 6:30 PM – 8:00 PM PST
Dinner: 5:30 PM – 6:30 PM
Contact Persons: Duc Bach; Lisa Gunther
RSVP Deadline: August 16, 2024
Drug Information Response Form: Acthar Dosing for Pediatric Patient with Infantile Spasms
Year: 2026
Region / City: Ohio
Topic: Pediatric Drug Dosing, Infantile Spasms
Document Type: Medical Response
Organization: The Ohio State University College of Pharmacy
Author: Hailey Baird
Target Audience: Medical Professionals, Pediatric Neurologists
Period of Effectiveness: 2026
Approval Date: 2026
Date of Last Update: 2026
Dalteparin dosing and monitoring for haemodialysis circuit patency at Royal Infirmary of Edinburgh
Year: 2026
Institution: Royal Infirmary of Edinburgh
Department: Renal Directorate
Document Type: Clinical guideline
Intended Audience: Healthcare professionals in nephrology and dialysis units
Indication: Prevention of clotting in extracorporeal haemodialysis circuits
Dosage Information: Weight-based Dalteparin administration at start of dialysis
Monitoring: Anti-Xa levels at 1 and 4 hours post-administration under specific conditions
Contraindications: Systemic anticoagulation, invasive procedures within 24 hours, hypersensitivity to heparin or LMWHs, haemophilia, severe thrombocytopenia, recent cerebral haemorrhage, severe liver disease, acute peptic ulceration
Side Effects: Skin rashes, minor bruising, systemic allergic reactions, excessive bleeding, thrombocytopenia, skin necrosis, hyperkalaemia
Reversal: Protamine sulphate if severe bleeding occurs during or within 2 hours post-dialysis
Topics: Helixor Mistletoe Dosing